SCHEMBL4931253

SCHEMBL4931253

Clc1ccc(Nc2cncc(-c3ccncc3)c2)cc1

nearest known ligand 0.56

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
XDH P47989 6/20 0.56
SLC22A12 Q96S37 6/20 0.56
CNR1 P21554 2/20 0.51
TDP2 O95551 1/20 0.50
KCNH2 Q12809 1/20 0.50
SCN5A Q14524 1/20 0.50
SCN9A Q15858 1/20 0.50
KDR P35968 1/20 0.48
ALPL P05186 2/20 0.48
ESR1 P03372 1/20 0.48
CHRNB4 P30926 1/20 0.45
CHRNA3 P32297 1/20 0.45
PDGFRB P09619 1/20 0.44
PDGFRA P16234 1/20 0.44
MEN1 O00255 2/20 0.43
KMT2A Q03164 2/20 0.43
MAPT P10636 1/20 0.43
CYP3A4 P08684 1/20 0.41
CYP2D6 P10635 1/20 0.41
PSEN1 P49768 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4187369 0.85 XDH (0.57) XDHSLC22A12CNR1TDP2KCNH2
SCHEMBL4162173 0.83 XDH (0.58) XDHSLC22A12CNR1TDP2KDR
SCHEMBL4187435 0.80 XDH (0.56) XDHSLC22A12CNR1TDP2KCNH2
SCHEMBL4154749 0.78 ROCK2 (0.51) CNR1KDRALPLMAP4K4
SCHEMBL4195748 0.78 KCNH2 (0.52) XDHSLC22A12CNR1TDP2KCNH2
SCHEMBL4191619 0.78 XDH (0.54) XDHSLC22A12CNR1ALPL
SCHEMBL10570649 0.78 KMT2A (0.61) SCN9AKDRESR1MEN1KMT2A
SCHEMBL4154890 0.77 XDH (0.60) XDHSLC22A12CNR1TDP2KCNH2
SCHEMBL4929361 0.76 KMT2A (0.66) CNR1MEN1KMT2AMAPTMAP4K4
SCHEMBL4920244 0.76 ALDH1A1 (0.66) ALPLCYP3A4CYP2D6PSEN1PSEN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20080194584-A1 Nitrogen Heteroaromatic Compounds Which Bind To The Active Site Of Protein Kinase Enzymes GALAPAGOS NV (BE) 2008-08-14 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080194584-A1 Nitrogen Heteroaromatic Compounds Which Bind To The Active Site Of Protein Kinase Enzymes ROCK1, TNK2, GRK1 XDH 407/4885SLC22A12 4756/4885CNR1 1765/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.